Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we investigate tissue-wide gene expression heterogeneity throughout a multifocal prostate cancer using the spatial transcriptomics (ST) technology. Utilizing a novel approach for deconvolution, we analyze the transcriptomes of nearly 6750 tissue regions and extract distinct expression profiles for the different tissue components, such as stroma, normal and PIN glands, immune cells and cancer. We distinguish healthy and diseased areas and thereby provide insight into gene expression changes during the progression of prostate cancer. Compared to pathologist annotations, we delineate the extent of cancer foci more accurately, interestingly without link t...
Background: Genomic analyses of hundreds of prostate tumors have defined a diverse ...
Prostate cancer is a common cancer type in men, yet some of its traits are still under-explored. One...
Given the dearth of gene mutations in prostate cancer, [1] ,[2] it is likely that genomic rearrangem...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Each cancer is unique, and therefore the use of general treatments are often suboptimal. If we can u...
Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve tre...
Every cancer tumor is unique, with characteristics that change over time. The evolution of a full-bl...
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized...
The tumor microenvironment plays a crucial role in both the development and progression of prostate ...
Prostate cancer is one of the most common cancer types worldwide, and its heterogeneity poses challe...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Prostate cancer affects millions of people worldwide. The current risk stratification and disease ma...
Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microa...
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-risk ...
Background: Genomic analyses of hundreds of prostate tumors have defined a diverse ...
Prostate cancer is a common cancer type in men, yet some of its traits are still under-explored. One...
Given the dearth of gene mutations in prostate cancer, [1] ,[2] it is likely that genomic rearrangem...
Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we invest...
Each cancer is unique, and therefore the use of general treatments are often suboptimal. If we can u...
Understanding the heterogeneous molecular landscape of prostate cancer is fundamental to improve tre...
Every cancer tumor is unique, with characteristics that change over time. The evolution of a full-bl...
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized...
The tumor microenvironment plays a crucial role in both the development and progression of prostate ...
Prostate cancer is one of the most common cancer types worldwide, and its heterogeneity poses challe...
While progression from normal prostatic epithelium to invasive cancer is driven by molecular alterat...
Prostate cancer affects millions of people worldwide. The current risk stratification and disease ma...
Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microa...
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-risk ...
Background: Genomic analyses of hundreds of prostate tumors have defined a diverse ...
Prostate cancer is a common cancer type in men, yet some of its traits are still under-explored. One...
Given the dearth of gene mutations in prostate cancer, [1] ,[2] it is likely that genomic rearrangem...